Advances in Obesity, Endocrinology, and Diabetes is a leading open-access journal dedicated to publishing cutting-edge research and significant advancements in the fields of obesity, endocrinology, and diabetes. Our mission is to foster a deeper understanding of these critical health issues and to promote innovative approaches to prevention, treatment, and management. We envision a world where scientific discoveries translate into improved health outcomes and quality of life for individuals affected by these conditions.
Scope
Our journal covers a broad spectrum of topics within the domains of obesity, endocrinology, and diabetes, including but not limited to:
- Obesity: Studies on causes, epidemiology, prevention strategies, lifestyle interventions, surgical treatments, and pharmacotherapy
- Endocrinology: Research on hormonal regulation, endocrine gland disorders, metabolic syndromes, and new therapeutic approaches
- Diabetes: Insights into pathophysiology, diagnosis, complications, and management of type 1, type 2, and gestational diabetes, as well as advancements in diabetes care and technology
Our journal covers a broad spectrum of topics within the domains of obesity, endocrinology, and diabetes, including but not limited to:
- Original Article: Should report original research not previously published or being considered for publication elsewhere. Submission of a manuscript to this journal gives the publisher the right to publish that paper if it is accepted. Manuscripts may be edited to improve clarity and expression.
- Short Communication: A short communication is a short version of "Original Article", whose methods, findings, data, etc. don't justify a full length paper, but still contain original findings with significant research merits, but are generally much more straightforward.
- Editorial: These are usually submitted by the journal editors, about any cutting edge topics that relates to endocrinology and metabolism, maximum 3000 words will be welcomed for consideration.
- Letter to the Editor: Authors are encouraged to write about any cutting edge topics that relates to endocrinology and metabolism, or the commentaries on this journal's previous publications, maximum 3000 words will be welcomed for consideration.
- Review: In-depth reviews of recent developments are welcome and will undergo peer review. Reviews should have an abstract of up to 350 words.
- Case Report : Authors are required to follow the CARE Case Report Guidelines and checklist when preparing the case report manuscript, otherwise, it may be returned for resubmission.
- Summary of Meeting: Brief of medical conferences in up-to-date topics of clinical medicine research and relevant fields will be considered for publication in Advances in Obesity, Endocrinology, and Diabetes
